Clinical curative effect and safety of balloon sinuplasty in children with chronic rhinosinusitis

Liu, Jia; Zhao, Zhiyuan; Chen, Yang; Xu, Bin; Dai, Jiren; Fu, Yong

doi:10.1016/j.ijporl.2017.06.026

Cited by 13 publications

(19 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Soler ZM et al reported a significant improvement in SN-5 (mean score = 1.7 postoperatively vs. mean score = 4.8 preoperatively) [24]. In a prospective study conducted by Liu J et al, VAS score was significantly improved after the procedure (preop VAS score = 17.86 ± 7.59 vs. post op VAS score = 1.68 ± 3.53) [25]. Additionally, findings of the two experimental controlled trials supported the aforementioned findings [29,32].…”

Section: Study Characteristicsmentioning

confidence: 96%

“…QoL and other pertinent measures were reported for the long-term follow-up (12 months or more). According to longitudinal studies, SN-5 results of the long-term follow-up showed a significant improvement in the score with sustained results [25,28,29,31,32,35,36]. According to a long-term evalution by VAS, a dramatic drop in the score was found in two cohorts of patients after a 1 year follow-up [25,29].…”

Section: Study Characteristicsmentioning

confidence: 98%

“…According to a long-term evalution by VAS, a dramatic drop in the score was found in two cohorts of patients after a 1 year follow-up [25,29]. In addition, long-term examination revealed that balloon sinuplasty had greater and more sustained improvement after 1 year (6 months postoperative VAS score of 1.68 ± 3.53 vs. 1-year postoperative score of 0.57 ± 1.60) [25]. Results of the two experimental controlled trials supported the aforementioned findings [29,32].…”

Section: Study Characteristicsmentioning

confidence: 98%

“…According to longitudinal studies, SN-5 results of the long-term follow-up showed a significant improvement in the score with sustained results [25,28,29,31,32,35,36]. According to a long-term evalution by VAS, a dramatic drop in the score was found in two cohorts of patients after a 1 year follow-up [25,29]. In addition, long-term examination revealed that balloon sinuplasty had greater and more sustained improvement after 1 year (6 months postoperative VAS score of 1.68 ± 3.53 vs. 1-year postoperative score of 0.57 ± 1.60) [25].…”

Section: Study Characteristicsmentioning

confidence: 98%

“…There is, however, no current agreement whether BCS is safe or efficacious in treating children with CRS. Since EPOS 2012, a number of studies have been carried out to determine the efficacy of BCS in pediatric CRS [24,25,[28][29][30][31][32][33]. The majority of these studies were pooled in a previous meta-analysis [34], demonstrating that BCS can significantly improve CRS symptoms among the pediatric group using a parent-reported scale, Sino-Nasal 5 (SN-5) QoL questionnaire [24,28,29,35,36].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Efficacy and safety of paranasal sinus balloon catheter dilation in pediatric chronic rhinosinusitis: A systematic review

Mirza

Shawli

Alandejani

et al. 2020

Journal of Otolaryngology - Head & Neck Surgery

View full text Add to dashboard Cite

Objective Chronic rhinosinusitis (CRS) negatively affects quality of life (QoL), and balloon catheter sinuplasty (BCS) has shown good outcomes in adult patients. However, there has not been much research on the effects of BCS on pediatric patients. The objective of this review is to systematically assess the literature for studies demonstrating the effectiveness and safety of BCS in pediatric CRS patients. Data sources PubMed, Embase and Cochrane Library. Study selection We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis recommendations (PRISMA) to conduct our study. Observational- and interventional-based studies reporting efficacy and/or side effects of BCS among pediatric populations were included. Efficacy was evaluated by clinically reliable measures including Sino-Nasal 5 (SN-5) QoL scale. Antibiotic usage and revision surgery were also evaluated. Data extraction Articles were screened, and data were obtained. Study design, sample size and demographics, treated sinuses, criteria of inclusion, adjunct procedure(s), follow-up time, and outcomes measured were reported. Main findings Out of 112 articles identified, 10 articles were included: two interventional controlled trials and eight observational studies. All studies evaluating QoL by SN-5 showed a remarkable reduction in SN-5 score postoperatively. Improvement in the computed tomography (CT) and endoscopic findings for up to 1 year after operation was reported. Furthermore, the majority of patinets treated with BCS did not recieve any course of sinusitis-indicated antibiotics during long-term follow-up, and they had low surgical revision rates. Minor side effects were reported, most commonly synechia. Conclusion Available evidence suggests that BCS is safe and effective for the treatment of CRS in pediatric patients. Future randomized controlled studies with large sample size are warranted. Such studies can further determine the efficacy of BCS in managing children with CRS.

show abstract

Section: Study Characteristicsmentioning

confidence: 96%

Section: Study Characteristicsmentioning

confidence: 98%

Section: Study Characteristicsmentioning

confidence: 98%

Section: Study Characteristicsmentioning

confidence: 98%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Efficacy and safety of paranasal sinus balloon catheter dilation in pediatric chronic rhinosinusitis: A systematic review

Mirza

Shawli

Alandejani

et al. 2020

Journal of Otolaryngology - Head & Neck Surgery

View full text Add to dashboard Cite

show abstract

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

518

479

View full text Add to dashboard Cite

I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.

show abstract